The company
UnitedHealth Group Incorporated Common Stock (DE)
UNH · NYSE
UNH stood above a rising 150-day average in 26 of the last 52 weekly readings, including each of the last 2 weeks. It is 11.6% above that average now. Managed Care & Insurers: 80% of its 10 stocks in an uptrend (+10 points in four weeks); Health Care: 28% (−6 points in four weeks).
Statistics
- Rotation
- Just started moving
- Weeks in an uptrend
- 2 in a row
- Industry in uptrend
- 80% +10 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $1.9M
- Officials’ trades on record
- 371
- Institutions holding
- 3,218 (+323)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 26 of 52 weeks.
Managed Care & Insurers: Most of its stocks are in an uptrend and the share has climbed sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has been slipping.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
371 disclosed lines: House 296, Senate 30, executive 45; 92 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| Maria Elvira Salazar House: U.S. House ClerkFL27 | sold | $1k–$15k | 24 Sep 2026filed 7 Oct 2026 |
| Kevin Hern House: U.S. House ClerkOK01 | soldjoint | $15k–$50k | 23 Sep 2026filed 13 Oct 2026 |
| Kevin Hern House: U.S. House ClerkOK01 | soldjoint | $15k–$50k | 10 Sep 2026filed 25 Sep 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $100k–$250k | 21 Aug 2026filed 8 Oct 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $100k–$250k | 31 Jul 2026filed 22 Sep 2026 |
| Richard McCormick House: U.S. House ClerkGA06 | sold | $1k–$15k | 30 Jul 2026filed 14 Aug 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $1k–$15k | 17 Jul 2026filed 22 Sep 2026 |
| Dan Newhouse House: U.S. House ClerkWA04 | soldspouse | $1k–$15k | 10 Jul 2026filed 17 Jul 2026 |
| Richard McCormick House: U.S. House ClerkGA06 | sold | $1k–$15k | 12 Jun 2026filed 9 Jul 2026 |
| Richard McCormick House: U.S. House ClerkGA06 | sold | $1k–$15k | 12 Jun 2026filed 9 Jul 2026 |
| John Boozman Senate: U.S. Senate eFDSenator | boughtjoint | $1k–$15k | 4 Jun 2026filed 13 Jul 2026 |
| Maria Elvira Salazar House: U.S. House ClerkFL27 | sold | $1k–$15k | 4 Jun 2026filed 7 Jul 2026 |
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Patrick Hugh ConwayChief Executive Officer, Optum | sold | 1,169at $390.00 | 21 Aug 2026filed 25 Aug 2026 |
| Patrick Hugh ConwayChief Executive Officer, Optum | sold | 500at $410.00 | 5 Aug 2026filed 7 Aug 2026 |
| Patrick Hugh ConwayChief Executive Officer, Optum | sold | 800at $355.00 | 23 Apr 2026filed 27 Apr 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| BlackRock, Inc.added · filed 7 Aug 2026 | 76,863,061$31.9B | +3,395,530+4.6% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 59,311,525$24.7B | +440,748+0.7% |
| STATE STREET CORPadded · filed 7 Aug 2026 | 45,633,267$19.0B | +301,081+0.7% |
| Capital World Investorsadded · filed 12 Aug 2026 | 29,887,932$12.4B | +2,104,517+7.6% |
| FMR LLCadded · filed 13 Aug 2026 | 27,992,995$11.6B | +15,973,949+132.9% |
| VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 2026 | 24,483,234$10.2B | +446,730+1.9% |
| GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 2026 | 21,751,937$9.0B | -1,016,758−4.5% |
| JPMORGAN CHASE & COnew · filed 12 Aug 2026 | 20,246,047$8.5B | +20,246,047 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INCreduced · filed 14 Aug 2026 | 19,830,588$8.2B | -987,167−4.7% |
| Sixth Street Partners Management Company, L.P.new · filed 14 Aug 2026 | 19,830,588$8.2B | +19,830,588 |
News
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.